Search

Detailsite | MedUni Vienna ... conducted by Daniel Schramek within the framework of his dissertation at IMBA, Lukas Kenner and his team from MedUni Vienna have played a substantial role in the evaluation of the tumours. It has been found at the laboratory of the Department of Clinical Pathology and Ludwig Boltzmann Cancer Research Institute (LBI-CR) at MedUni Vienna that in mice that lack the bone gene RANKL no or a much lower breast cancer growth was observed than in mice where the RANKL gene was active. In addition, the working group headed by Lukas Kenner identified the cell types in the mammary gland from which the malignant... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/how-hormones-can-trigger-breast-cancer/

Special transcription factor and its target genes as an important approach for therapy at rare leukaemia type identified ... malignant T-cell lymphoma, which particularly affects children and young adults. Chemotherapy is used as the standard therapy, but relapses often occur. BATF3 as key transcription factor for the signal transfer at ALCL A group of researchers of MedUni Vienna around Olaf Merkel and Lukas Kenner (also at the... https://www.meduniwien.ac.at/web/en/ueber-uns/news/news-im-september-2021/spezieller-transkriptionsfaktor-und-seine-zielgene-als-wichtiger-ansatzpunkt-fuer-therapie-bei-seltener-blutkrebsart-identifiziert/

Special transcription factor and its target genes as an important approach for therapy at rare leukaemia type identified ... malignant T-cell lymphoma, which particularly affects children and young adults. Chemotherapy is used as the standard therapy, but relapses often occur. BATF3 as key transcription factor for the signal transfer at ALCL A group of researchers of MedUni Vienna around Olaf Merkel and Lukas Kenner (also at the... https://www.meduniwien.ac.at/web/en/ueber-uns/news/news-im-september-2021/spezieller-transkriptionsfaktor-und-seine-zielgene-als-wichtiger-ansatzpunkt-fuer-therapie-bei-seltener-blutkrebsart-identifiziert/medicine-science/

Detailsite | MedUni Vienna ..., Ruggeri BA, Cheng M, Eferl R, Egger G, Penninger JM, Jaeger U, Moriggl R, Inghirami G, Kenner L „PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas” Wissenschafter an den Medizinischen Universitäten Wien und Graz sowie dem LBI-CR und der Veterenärmedizinischen Universität Wien um Lukas Kenner, Daniela Laimer-Gruber, Helmut Dolznig, Karoline Kollmann und Paul Vesely untersuchten einen besonders aggressiven Tumor, das anaplastische großzellige Non-Hodgkin Lymphom (anaplastic large cell lymphoma – ALCL). Unter Verwendung eines genetischen Modells, das diese Erkrankung in... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/in-german-sanofi-stiftung-zeichnet-wiener-wissenschafterinnen-aus/

New method allows more targeted measurement of thyroid hormone action in tissue ... concentrations in skeletal muscle and liver: An in vivo NMRS study." Hannes Beiglböck, Peter Wolf, Lorenz Pfleger, Burak Caliskan, Paul Fellinger, Georg Zettinig, Christian Heinz Anderwald, Lukas Kenner, Siegfried Trattnig, Alexandra Kautzky-Willer, Martin Krššák, Michael Krebs. DOI: 10.1210/clinem/dgaa... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-oktober-2020/new-method-allows-more-targeted-measurement-of-thyroid-hormone-action-in-tissue/

New method allows more targeted measurement of thyroid hormone action in tissue ... concentrations in skeletal muscle and liver: An in vivo NMRS study." Hannes Beiglböck, Peter Wolf, Lorenz Pfleger, Burak Caliskan, Paul Fellinger, Georg Zettinig, Christian Heinz Anderwald, Lukas Kenner, Siegfried Trattnig, Alexandra Kautzky-Willer, Martin Krššák, Michael Krebs. DOI: 10.1210/clinem/dgaa... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-oktober-2020/new-method-allows-more-targeted-measurement-of-thyroid-hormone-action-in-tissue/medicine-science/

Möglicher Auslöser von chronisch-entzündlichen Darmerkrankungen entdeckt ... colitis and inflammatory bowel disease; Bernadette Mödl, Monira Awad, Daniela Zwolanek, Irene Scharf, Katharina Schwertner, Danijela Milovanovic, Doris Moser, Katy Schmidt, Petra Pjevac, Bela Hausmann, Dana Krauß, Thomas Mohr, Jasmin Svinka1, Lukas Kenner, Emilio Casanova, Gerald Timelthaler, Maria... https://www.meduniwien.ac.at/web/ueber-uns/news/2024/news-im-jaenner-2024/moeglicher-ausloeser-von-chronisch-entzuendlichen-darmerkrankungen-entdeckt/medizin-wissenschaft/

Möglicher Auslöser von chronisch-entzündlichen Darmerkrankungen entdeckt ... colitis and inflammatory bowel disease; Bernadette Mödl, Monira Awad, Daniela Zwolanek, Irene Scharf, Katharina Schwertner, Danijela Milovanovic, Doris Moser, Katy Schmidt, Petra Pjevac, Bela Hausmann, Dana Krauß, Thomas Mohr, Jasmin Svinka1, Lukas Kenner, Emilio Casanova, Gerald Timelthaler, Maria... https://www.meduniwien.ac.at/web/ueber-uns/news/2024/news-im-jaenner-2024/moeglicher-ausloeser-von-chronisch-entzuendlichen-darmerkrankungen-entdeckt/

New CBmed Core Lab opened at MedUni Vienna ...All News – University, Medicine & Science from left: n.r.: Georg Steiner (CEO TissueGnostics), Thomas Pieber (CSO K1-Kompetenzzentrum CBmed), Rector Markus Müller, Robert Fasching (CBmed), Rudolf Oehler (Cbmed/MedUni Vienna), Vice-rector Michaela Fritz, Franz Wurm (MedUni Vienna/Supervisory Board CBmed), Lukas Kenner (MedUni Vienna). (Vienna, 08 July 2016) – The Austrian research center CBmed (Center for Biomarker Research in Medicine) officially opens a new Core Lab at the Medical University of Vienna. The proteomics laboratory uses completely new methods to identify... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-from-july-2016/new-cbmed-core-lab-opened-at-meduni-vienna/

New CBmed Core Lab opened at MedUni Vienna ...All News – University, Medicine & Science from left: n.r.: Georg Steiner (CEO TissueGnostics), Thomas Pieber (CSO K1-Kompetenzzentrum CBmed), Rector Markus Müller, Robert Fasching (CBmed), Rudolf Oehler (Cbmed/MedUni Vienna), Vice-rector Michaela Fritz, Franz Wurm (MedUni Vienna/Supervisory Board CBmed), Lukas Kenner (MedUni Vienna). (Vienna, 08 July 2016) – The Austrian research center CBmed (Center for Biomarker Research in Medicine) officially opens a new Core Lab at the Medical University of Vienna. The proteomics laboratory uses completely new methods to identify... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-from-july-2016/new-cbmed-core-lab-opened-at-meduni-vienna/university/

Persons

Webseiten-Inhalte